dipivefrin has been researched along with Conjunctival Diseases in 4 studies
dipivefrin: used in treatment of both primary & open angle glaucoma; RN given refers to (+-)-isomer
dipivefrin : The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.
Conjunctival Diseases: Diseases involving the CONJUNCTIVA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect on intraocular pressure (IOP) and aqueous flare of topical applications of latanoprost and dipivefrin alone or combined." | 9.08 | Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. ( Alm, A; Mäepea, O; Widengård, I, 1998) |
| "To investigate the effect on intraocular pressure (IOP) and aqueous flare of topical applications of latanoprost and dipivefrin alone or combined." | 5.08 | Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. ( Alm, A; Mäepea, O; Widengård, I, 1998) |
| "Dipivefrin hydrochloride is a lipophilic prodrug for epinephrine hydrochloride, allowing lower concentration of the drug to achieve the same intraocular pressure lowering effect and having also less harmful effects than epinephrine hydrochloride." | 1.29 | Corneal vascularization and opacification during long-term use of dipivefrin. ( Hakala, T; Helin, H; Krootila, K; Salminen, L, 1995) |
| "Metipranolol seems to be a less toxic phenol derivative of practolol." | 1.28 | Conjunctival keratinisation, an abnormal reaction to an ocular beta-blocker. ( de Keizer, RJ; de Wolff-Rouendaal, D; Derous, D; Soudijn, W, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salminen, L | 1 |
| Krootila, K | 1 |
| Helin, H | 1 |
| Hakala, T | 1 |
| Widengård, I | 1 |
| Mäepea, O | 1 |
| Alm, A | 1 |
| Derous, D | 1 |
| de Keizer, RJ | 1 |
| de Wolff-Rouendaal, D | 1 |
| Soudijn, W | 1 |
| Liesegang, TJ | 1 |
1 trial available for dipivefrin and Conjunctival Diseases
| Article | Year |
|---|---|
Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.
Topics: Adrenergic Agonists; Aged; Blood-Aqueous Barrier; Conjunctival Diseases; Drug Administration Schedul | 1998 |
3 other studies available for dipivefrin and Conjunctival Diseases
| Article | Year |
|---|---|
Corneal vascularization and opacification during long-term use of dipivefrin.
Topics: Blepharitis; Conjunctival Diseases; Corneal Neovascularization; Corneal Opacity; Epinephrine; Female | 1995 |
Conjunctival keratinisation, an abnormal reaction to an ocular beta-blocker.
Topics: Chemical Phenomena; Chemistry; Conjunctival Diseases; Epinephrine; Female; Humans; Keratins; Metipra | 1989 |
Bulbar conjunctival follicles associated with dipivefrin therapy.
Topics: Aged; Conjunctival Diseases; Epinephrine; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; T | 1985 |